The Journal of dermatological treatment · 2012
Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichophyton mentagrophytes using an in vitro test system.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gupta A K, Brintnell W
Аннотация
BACKGROUND: Ozone gas possesses antimicrobial potential against many microorganisms, however limited data exist on its effect on the keratinophilic dermatophyte fungi Trichophyton rubrum and Trichophyton mentagrophytes; two organisms commonly isolated as the etiological agent in onychomycosis and tinea pedis patients.
OBJECTIVE/METHODS: We utilized a commercial ozone gas generation device for testing the fungicidal effects of ozone on ATCC strains of Trichophyton rubrum and Trichophyton mentagrophytes.
RESULTS: We demonstrated that ozone gas is effective in killing > 99% of viable fungi present in various experimental systems.
CONCLUSION: This work represents a proof of principle regarding ozone gas and its fungicidal effect on dermatophyte fungi. From these findings, further ozone gas studies will be conducted to develop a novel adjunct therapy for use in parallel with current antifungal medications and/or devices to better treat onychomycosis and tinea pedis patients in the short and long term.
OBJECTIVE/METHODS: We utilized a commercial ozone gas generation device for testing the fungicidal effects of ozone on ATCC strains of Trichophyton rubrum and Trichophyton mentagrophytes.
RESULTS: We demonstrated that ozone gas is effective in killing > 99% of viable fungi present in various experimental systems.
CONCLUSION: This work represents a proof of principle regarding ozone gas and its fungicidal effect on dermatophyte fungi. From these findings, further ozone gas studies will be conducted to develop a novel adjunct therapy for use in parallel with current antifungal medications and/or devices to better treat onychomycosis and tinea pedis patients in the short and long term.